Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Unveiling disulfidptosis-related biomarkers and predicting drugs in Alzheimer’s disease

30 Aug 2024

Abstract excerpt

Alzheimer's disease is the predominant form of dementia, and disulfidptosis is the latest reported mode of cell death that impacts various disease processes. This study used bioinformatics to analyze genes associated with disulfidptosis in Alzheimer's disease comprehensively. Based on the public datasets, the differentially expressed genes associated with disulfidptosis were identified, and immune cell...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Bioinformatics and Genomic Networks
Share to Neuroinflammation and Neurodegeneration Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39215110
DOI: 10.1038/s41598-024-70893-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Unveiling disulfidptosis-related biomarkers and predicting drugs in Alzheimer’s diseasePMID 39215110Read ↗

Identification of disulfidptosis-related genes and subgroups in Alzheimer’s diseaseSemantic proximity Read ↗

Machine learning identification and immune infiltration of disulfidptosis‐related Alzheimer's disease molecular subtypesSemantic proximity Read ↗

Identification and validation of oxidative stress and immune-related hub genes in Alzheimer’s disease through bioinformatics analysisSemantic proximity Read ↗

Target oxidative stress-induced disulfidptosis: novel therapeutic avenues in Parkinson’s diseaseSemantic proximity Read ↗

Identification of oxidative stress-related genes differentially expressed in Alzheimer’s disease and construction of a hub gene-based diagnostic modelSemantic proximity Read ↗

Uncovering the Oxidative Stress Mechanisms and Targets in Alzheimer's Disease by Integrating Phenotypic Screening Data and Polypharmacology Networks.Semantic proximity Read ↗

Comprehensive Analysis Reveals A Six-Gene Signature and Associated Drugs in Alzheimer DiseaseSemantic proximity Read ↗

Hub Genes, Diagnostic Model, and Predicted Drugs Related to Iron Metabolism in Alzheimer's DiseaseSemantic proximity Read ↗

Identification of biomarkers and pathways to identify novel therapeutic targets in Alzheimer’s disease: Insights from a systems biomedicine perspectiveSemantic proximity Read ↗

Integrated Bioinformatics and Ensemble Learning Reveal Diagnostic Modeling and Drug Discovery in Alzheimer’s DiseaseSemantic proximity Read ↗

Identification of Common Molecular Signatures Shared between Alzheimer’s and Parkinson’s Diseases and Therapeutic Agents Exploration: An Integrated Genomics ApproachSemantic proximity Read ↗

Neuroinflammation inhibition and neuroprotective effects of purpurin, a potential anti‐AD compound, screened via network proximity and gene enrichment analysesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.